ArticleAlzheimer's research & therapy2026
A new paradigm for stratified cognitive assessment: fusing serum Raman spectroscopy and ensemble learning.
Article in Alzheimer's research & therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundIn China, the growing need for stratified cognitive assessment demands portable solutions. However, in community-based screening, neuropsychological assessments suffer from low acceptance and low efficiency. Thus, we aimed to develop a serum Raman spectroscopy-based ensemble learning approach for graded cognitive screening, and explore the Raman spectral features of cognitive impairment and their mapping relationship to brain function.
methodsWe recruited 220 subjects for modeling and 40 subjects for validation. Ensemble learning model was built using serum Raman spectra. High-weight features were analyzed for inter-group differences, graph theory properties, and associations with brain networks.
resultsWe developed a serum Raman spectroscopy-based ensemble learning approach for graded cognitive screening. The model distinguishing normal cognition, mild cognitive impairment, and dementia achieved area under curve of 0.92 (testing) and 0.89 (validation). Raman shifts at 1602, 1002, and 1666 cm⁻¹ showed intensity and nodal changes, linking their modulation to both cognitive decline and altered posterior default mode network (pDMN) interactions.
conclusionsThe Raman spectroscopy-based ensemble learning model was powerful for cognitive screening. The alteration at the 1602, 1002, and 1666 cm⁻¹ represented key Raman signatures of cognitive impairment, reflecting impaired pDMN-related inter-network interactions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.